The SEP domain of p47 acts as a reversible competitive inhibitor of cathepsin L

Michael Soukenik(Leibniz-Forschungsinstitut für Molekulare Pharmakologie), Hartmut Oschkinat(Leibniz Association), Dorit K. Nägler(Klinikum Ludwigshafen), Dirk Labudde(Hochschule Mittweida), Volker Sievert(Max Planck Institute for Molecular Genetics), Dietmar Leitner(Leibniz-Forschungsinstitut für Molekulare Pharmakologie), Anne Diehl(Leibniz-Forschungsinstitut für Molekulare Pharmakologie), Martina Leidert(Leibniz-Forschungsinstitut für Molekulare Pharmakologie), Linda Ball(Leibniz-Forschungsinstitut für Molekulare Pharmakologie), Annette Lechner(Ludwig-Maximilians-Universität München), Konrad Büssow(Helmholtz Centre for Infection Research)
FEBS Letters
September 25, 2004
10.1016/j.febslet.2004.09.037
Cited by 19

Related Papers

AhR sensing of bacterial pigments regulates antibacterial defence
|Nature|2014|369
Rapid Proton-Detected NMR Assignment for Proteins with Fast Magic Angle Spinning
|Journal of the American Chemical Society|2014|317
Proteomic Identification of Protease Cleavage Sites Characterizes Prime and Non-prime Specificity of Cysteine Cathepsins B, L, and S
|Journal of Proteome Research|2011|190
Host monitoring of quorum sensing during <i>Pseudomonas aeruginosa</i> infection
|Science|2019|166
Major Increase in Endopeptidase Activity of Human Cathepsin B upon Removal of Occluding Loop Contacts
|Biochemistry|1997|165